Showing results (71-80 of 1,607) with videos related to

Sort By:
Pageof 161
JAMA Oncology|September 4, 2025
Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis: A Randomized Clinical TrialJonathan T Yang, Divya Yerramilli, Elena Pentsova, et al.
JAMA Oncology|May 13, 2021
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical TrialPeter S Hall, Daniel Swinson, David A Cairns, et al.
JAMA Oncology|June 5, 2020
Association of Mental Health Treatment With Outcomes for US Veterans Diagnosed With Non-Small Cell Lung CancerJacob E Berchuck, Craig S Meyer, Ning Zhang, et al.
JAMA Oncology|May 20, 2021
Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 TrialAnna van der Voort, Mette S van Ramshorst, Erik D van Werkhoven, et al.
JAMA Oncology|August 5, 2021
Applying a Life Course Biological Age Framework to Improving the Care of Individuals With Adult Cancers: Review and Research RecommendationsJeanne S Mandelblatt, Tim A Ahles, Marc E Lippman, et al.
JAMA Oncology|November 29, 2016
Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer DatabaseJ Alejandro Rauh-Hain, Alexander Melamed, Alexi Wright, et al.
JAMA Oncology|November 29, 2016
Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell LymphomaYong Yang, Jian-Zhong Cao, Sheng-Min Lan, et al.
JAMA Oncology|December 16, 2016
Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Among Patients With Early-Onset Colorectal CancerRachel Pearlman, Wendy L Frankel, Benjamin Swanson, et al.
JAMA Oncology|December 16, 2016
Effect of Selumetinib and MK-2206 vs Oxaliplatin and Fluorouracil in Patients With Metastatic Pancreatic Cancer After Prior Therapy: SWOG S1115 Study Randomized Clinical TrialVincent Chung, Shannon McDonough, Philip A Philip, et al.
JAMA Oncology|December 6, 2016
Alternating Treatment With Pazopanib and Everolimus vs Continuous Pazopanib to Delay Disease Progression in Patients With Metastatic Clear Cell Renal Cell Cancer: The ROPETAR Randomized Clinical TrialGeert A Cirkel, Paul Hamberg, Stefan Sleijfer, et al.
Pageof 161